Last reviewed · How we verify

bismuth subnitrate

unknown active ✓ Verified May 2026

bismuth subnitrate is a bismuth subnitrate drug. It is currently in unknown development.

Bismuth subnitrate is thought to work by exerting antimicrobial properties, although the exact mechanism is unclear.

Bismuth subnitrate is a small molecule compound with the synonyms including bismuth subnitrate, heavy bismuth subnitrate, and bismuthum subnitrucum. It has been studied in clinical trials for various conditions, including breast cancer, colon cancer, and lung cancer, as part of the Comskil Training assessment through videorecording and patient surveys.

At a glance

Generic namebismuth subnitrate
Drug classbismuth subnitrate
Therapeutic areaInfectious Disease
Phaseunknown

Mechanism of action

In simple terms, bismuth subnitrate is believed to help kill certain types of bacteria that can cause infections. It does this by disrupting the bacteria's ability to function and multiply, ultimately helping to clear up the infection. However, more research is needed to fully understand how bismuth subnitrate works and how it compares to other treatments.

Approved indications

No approved indications tracked.

Common side effects

Key clinical trials

Primary sources

Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.

SourceUsed for
ClinicalTrials.govTrial enrolment, design, endpoints, results

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:

Frequently asked questions about bismuth subnitrate

What is bismuth subnitrate?

bismuth subnitrate is a bismuth subnitrate drug.

How does bismuth subnitrate work?

Bismuth subnitrate is thought to work by exerting antimicrobial properties, although the exact mechanism is unclear.

What drug class is bismuth subnitrate in?

bismuth subnitrate belongs to the bismuth subnitrate class. See all bismuth subnitrate drugs at /class/bismuth-subnitrate.

What development phase is bismuth subnitrate in?

bismuth subnitrate is in unknown.

What are the side effects of bismuth subnitrate?

Common side effects of bismuth subnitrate include Appendicolith, Blood phosphorus increased, Appendicitis, Ventricular fibrillation, Myasthenia gravis, Blood uric acid increased.

Related

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing